Your browser doesn't support javascript.
loading
CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.
Puntambekar, Shweta S; Moutinho, Miguel; Lin, Peter Bor-Chian; Jadhav, Vaishnavi; Tumbleson-Brink, Danika; Balaji, Ananya; Benito, Martin Alvarado; Xu, Guixiang; Oblak, Adrian; Lasagna-Reeves, Cristian A; Landreth, Gary E; Lamb, Bruce T.
Afiliación
  • Puntambekar SS; Stark Neurosciences Research Institute, Indiana University-School of Medicine, Indianapolis, IN, USA. sspuntam@iu.edu.
  • Moutinho M; Department of Medical and Molecular Genetics, Indiana University-School of Medicine, Indianapolis, IN, USA. sspuntam@iu.edu.
  • Lin PB; Stark Neurosciences Research Institute, Indiana University-School of Medicine, Indianapolis, IN, USA.
  • Jadhav V; Department of Anatomy, Cell Biology and Physiology, Indiana University-School of Medicine, Indianapolis, IN, USA.
  • Tumbleson-Brink D; Stark Neurosciences Research Institute, Indiana University-School of Medicine, Indianapolis, IN, USA.
  • Balaji A; Indiana Biomedical Gateway (IBMG) Program, Indiana University-School of Medicine, Indianapolis, IN, USA.
  • Benito MA; Stark Neurosciences Research Institute, Indiana University-School of Medicine, Indianapolis, IN, USA.
  • Xu G; Department of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, WA, USA.
  • Oblak A; Stark Neurosciences Research Institute, Indiana University-School of Medicine, Indianapolis, IN, USA.
  • Lasagna-Reeves CA; Department of Medical and Molecular Genetics, Indiana University-School of Medicine, Indianapolis, IN, USA.
  • Landreth GE; Stark Neurosciences Research Institute, Indiana University-School of Medicine, Indianapolis, IN, USA.
  • Lamb BT; Indiana Clinical and Translational Institute (CTSI), Summer Research Program (SRP), Indianapolis, IN, USA.
Mol Neurodegener ; 17(1): 47, 2022 06 28.
Article en En | MEDLINE | ID: mdl-35764973

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva / Receptor 1 de Quimiocinas CX3C / Amiloidosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Neurodegener Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva / Receptor 1 de Quimiocinas CX3C / Amiloidosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Neurodegener Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos